×
For best experience we recommend to activate Javascript in your browser.
Phospholipase C gamma 2 antibody (AA 1-1265)
The Mouse Polyclonal anti-Phospholipase C gamma 2 antibody has been validated for WB. It is suitable to detect Phospholipase C gamma 2 in samples from Human.
Quick Overview for Phospholipase C gamma 2 antibody (AA 1-1265) (ABIN2337260)
Target
See all Phospholipase C gamma 2 (PLCG2) Antibodies
Phospholipase C gamma 2 (PLCG2)
Reactivity
All reactivities for Phospholipase C gamma 2 antibodies
Human
Host
All hosts for Phospholipase C gamma 2 antibodies
Mouse
Clonality
All clonalities for Phospholipase C gamma 2 antibodies
Polyclonal
Conjugate
All conjugates for Phospholipase C gamma 2 antibodies
This Phospholipase C gamma 2 antibody is un-conjugated
Application
All applications for Phospholipase C gamma 2 antibodies
Western Blotting (WB)
Product Details anti-Phospholipase C gamma 2 Antibody
(hide)
Binding Specificity
All epitopes for Phospholipase C gamma 2 antibodies
AA 1-1265
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
PLCG2 (1-phosphatidylinositol 4,5-bisphosphate Phosphodiesterase gamma-2, Phosphoinositide Phospholipase C-gamma-2, Phospholipase C-IV, PLC-IV, Phospholipase C-gamma-2, PLC-gamma-2)
Purification
Purified by Protein A affinity chromatography.
Immunogen
Full length human PLCG2, aa1-1265 (AAH07565.1).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2.
Storage
-20 °C
Storage Comment
-20°C
Target Details for Phospholipase C gamma 2
(hide)
Target
Phospholipase C gamma 2 (PLCG2)
Alternative Name
PLCG2
Pathways
RTK Signaling , WNT Signaling , Fc-epsilon Receptor Signaling Pathway , Inositol Metabolic Process , Myometrial Relaxation and Contraction , Toll-Like Receptors Cascades , VEGF Signaling , BCR Signaling
Recently viewed
(hide)
Chat with us , powered by LiveChat